8.87
-0.11 (-1.22%)
-0.11 (-1.22%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Humanigen Inc | HGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.11 | -1.22% | 8.87 | 18:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.93 | 8.785 | 9.12 | 8.96 | 8.98 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 8.81 | 9.50 | 0.69 | - | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,592 | 347,011 | $ 8.96 | $ 3,109,176 | 644,432 | 7.75 - 16.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:28:30 | 1 | $ 8.90 | USD |
Humanigen Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 457.84M | 51.62M | 13.33M | $ - | $ - | -0.44 | -5.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 2.80k | 1.30% |
Humanigen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HGEN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.53 | 9.37 | 8.0361 | 8.70 | 456,133 | 0.34 | 3.99% |
| 1 Month | 11.14 | 13.00 | 7.75 | 9.27 | 672,242 | -2.27 | -20.38% |
| 3 Months | 10.85 | 16.00 | 7.75 | 11.27 | 749,493 | -1.98 | -18.25% |
| 6 Months | 10.85 | 16.00 | 7.75 | 11.27 | 749,493 | -1.98 | -18.25% |
| 1 Year | 10.85 | 16.00 | 7.75 | 11.27 | 749,493 | -1.98 | -18.25% |
| 3 Years | 10.85 | 16.00 | 7.75 | 11.27 | 749,493 | -1.98 | -18.25% |
| 5 Years | 10.85 | 16.00 | 7.75 | 11.27 | 749,493 | -1.98 | -18.25% |
Humanigen Description
| Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. |
